C=C1[C@]2(C)C=C(C)[C@@H](n3c(=O)n(-c4ccccc4)c(=O)n32)[C@]1(C)[C@@H]1CCCS1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?